mRNA Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
immunological response
2 years
No
Cornelis JA Punt, prof.MD
Principal Investigator
Radboud University Nijmegen Medical Centre, Dept of Medical Oncology
Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
NL22553.000.08
NCT00929019
June 2009
June 2014
Name | Location |
---|